Biotech investor Thilo Schroeder of Nextech Invest shares his take on biotech and discusses portfolio companies Revolution Medicines, Tubulis, and Circle Pharma
- May 2, 2025
- 1 min read
He describes the history of Nextech, including being an early investor in Blueprint Medicines and Peloton Therapeutics, and discusses the importance of investing in companies that have a wide moat to protect from today's fierce global competition.
.png){kind=logo}